NOBIVAC® CANINE 1-DAPPv + Cv

A modified live and killed virus vaccine for the immunisation of healthy dogs against canine distemper, adenovirus type-2, infectious canine hepatitis, parainfluenza, parvovirus and coronavirus

FOR ANIMAL USE ONLY

NOBIVAC® CANINE 1-DAPPv + Cv

Reg. No. G3895 (Act 36/1947)

Namibia Reg. No. V04/24.1/904 NS2

This vaccine may only be used by or under the supervision of persons registered in terms of or authorised in terms of section 23 (1) (c) of the Veterinary and Para-Veterinary Professions Act, 1982 (Act No. 19 of 1982).

INDICATIONS

A modified live and killed virus vaccine for the immunisation of healthy dogs against canine distemper, adenovirus type 2, infectious canine hepatitis, parainfluenza, parvovirus and coronavirus.

COMPOSITION

Modified live vaccine containing canine distemper, adenovirus type 2, parainfluenza virus, parvovirus type 2b strain and killed feline enteric coronavirus.

Maximum moisture content at release:  ≤ 5,5 %.

Contains gentamicin as a preservative.

STORAGE

  • Store between 2 °C and 8 °C.
  • Do not freeze.
  • Protect from light.

WARNINGS

  • DO NOT VACCINATE PREGNANT BITCHES.
  • Vaccinate only healthy, non-parasitised dogs.
  • Destroy any unused vaccine and dispose of all the empty vaccine containers and disposable equipment after use in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008).
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

  • Use new, non-chemically sterilised needles and syringes.
  • Do not mix with other vaccines.
  • Anaphylactic or hypersensitivity reactions may occur.

Antidote: Adrenaline, corticosteroids and antihistamines may all be indicated depending on the nature and severity of the reaction. 

DIRECTIONS FOR USE  – USE ONLY AS DIRECTED

  • Shake the Cv diluent vial and transfer its contents to the Nobivac® Canine 1-DAPPv vial aseptically.
  • Mix gently until dissolved.
  • Use entire contents immediately after rehydration.
  • Inject 1 mℓ subcutaneously or intramuscularly at 6 weeks of age or older.
  • Repeat dosage at 2 to 4 week intervals until the dog is 12 weeks old.
  • A minimum of two 1 mℓ doses are required for primary immunisation.
  • Although duration of immunity is at least 4 years for distemper, adenovirus (CAV1 and CAV2) and parvovirus, annual revaccination with one dose might be considered necessary if the individual risk profile or immune status so determines.
  • Annual revaccination with 1 dose is recommended for remaining indications.

PRESENTATION

25 x 1 dose (1 mℓ) Nobivac® Canine 1-DAPPv vials + the Cv part as diluent per poly vinyl chloride (pvc) tray.

5 x 10 dose (10 mℓ) Nobivac® Canine 1-DAPPv vials + the Cv part as diluent per poly vinyl chloride (pvc) tray.

Container must be sold as a unit.  Do not break seal or open before sale.

REGISTRATION HOLDER                                      

Intervet South Africa (Pty) Ltd.                           

20 Spartan Road                                                        

Spartan, 1619, RSA                                                    

Tel:  +27 (0) 11 923 9300                                          

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT

14 December 2010